Project Grant 2051652
Award Date
3/15/21
Completion Date
2/28/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Awardee
Cytorecovery Inc. (YE7LS83NPML7)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Blacksburg, VA, USA
Similar Awards
Biochip Labs Inc. received a $256,000 National Science Foundation Project Grant under the Engineering program (CFDA 47.041) for the period of June 1, 2021 through May 31, 2022. The grant funding supports the company's work to develop standardized and reproducible culture and activation methods for endothelial cells in microfluidic devices for drug screening applications. The NSF Engineering program seeks to improve quality of life and economic strength through engineering research and...
This $305,000 federal Project Grant was awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on April 15, 2025. The funding supports the development of a microchip-based technology by Cellecho, Inc. that leverages sound waves and electric fields to manipulate cells and sequentially deliver customizable combinations of genetic coding molecules. The broader goal is to make advanced cell engineering more accessible and...
The National Science Foundation Division of Industrial Innovation awarded $255,478 under the Engineering (47.041) federal grant program to Crossmhv, L.l.c. (doing business as Nascence) for the project "STTR PHASE I: RAPID-RELEASE CELL CULTURE PLATFORM FOR FLOW CYTOMETRY." The one-year project period runs from January 1, 2022 to December 31, 2022. Under this Project Grant, Nascence will develop a rapid-release cell culture platform to enable high-throughput flow cytometry analysis....
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
The National Science Foundation (NSF) Engineering program (CFDA 47.041) has awarded a $467,202 project grant to the Research Foundation of the City University of New York (RFCUNY) to develop an intelligent lab-on-chip device that can non-invasively monitor the maturation of stem cell-derived cardiomyocytes in real-time and apply adaptive biophysical stimulation to promote full cell maturation. The interdisciplinary research team from RFCUNY, City College of New York, and Rutgers University plans...
Cobio Diagnostics Inc. received a $256,000 Project Grant award from the National Science Foundation on April 1, 2021 to support work concluding on March 31, 2022. The grant was awarded under the NSF's Engineering program (CFDA 47.041), which aims to improve quality of life and economic strength through engineering research and education. Specifically, the grant funds Cobio Diagnostics' "SBIR PHASE I: PHAGE-AMPLIFIED IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TEST" project. This...
This Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) is supporting a collaborative research effort focused on developing an intelligent lab-on-chip device to monitor and promote the maturation of stem cell-derived cardiomyocytes. The $192,150 award to the New York Institute of Technology (NYIT) aims to create an integrated system that can non-invasively evaluate cardiomyocyte maturity in real-time and adaptively apply electrical and mechanical...
This $125,805 Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop new cell sorting technologies that can identify and separate cells based on changes in the activity of naturally occurring light-emitting molecules like NAD(P)H. The goal is to enable label-free, rapid identification and purification of cell populations, with a focus on stem cells and their functional subsets. The research will create a single cell deposition module to...
The National Science Foundation (NSF) awarded a $275,000 SBIR Phase I grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Om Therapeutics Inc. in La Jolla, CA. The goal of this project is to enable the discovery of new medicines at an unprecedented rate by empowering researchers to launch drug discovery programs quickly and cost-effectively. The innovation involves the ability to screen billions of unique small molecules against the entire human proteome in a...